Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-2-((S)-2-((S)-1-((3S,6R,11R,14S,17S,20S,23S,26S,31aS)-3-((1H-indol-3-yl)methyl)-11-((S)-2-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-4-(methylthio)butanamido)-3-methylbutanamido)-14-(2-amino-2-oxoethyl)-17-(4-hydroxybenzyl)-23-((R)-1-hydroxyethyl)-26-isobutyl-20-isopropyl-1,4,12,15,18,21,24,27-octaoxooctacosahydro-1H-pyrrolo[2,1-j][1,2,5,8,11,14,17,20,23,26]dithiaoctaazacyclononacosine-6-carbonyl)pyrrolidine-2-carboxamido)-4-(methylthio)butanamido)pentanediamide
ID: ALA1689449
Chembl Id: CHEMBL1689449
PubChem CID: 51351132
Max Phase: Preclinical
Molecular Formula: C86H123N19O20S4
Molecular Weight: 1871.31
Molecule Type: Protein
Associated Items: